Refine your search:
Central Nervous System Cutaneous General Information About Hodgkin Hodgkins Hodgkin's Disease Hodgkin's Lymphoma ✔X Leukemia, Adult Acute Leukemia, Adult Chronic Leukemia & Lymphoma ✔X Leukemia, Childhood Lymphatic Lymphoma Society ✔X Multiple Myeloma Nonhodgkins Non-Hodgkin's Lymphoma
- 37
-
Maintenance Rituximab for Follicular Lymphoma
National Cancer Institute — Rituximab (Rituxan®), follicular lymphoma, non-Hodgkin lymphoma, maintenance therapy In a pooled analysis of data from five clinical trials in patients with follicular lymphoma whose disease had relapsed or was resistant to treatment, those who ...More…
-
A Key to Understanding Lymphoma
National Institute of Arthritis — Lymphoma is the most common blood cancer and the third most common childhood cancer in the United States. Although there are many types of lymphoma, they all originate in the white blood cells (lymphocytes) that are part of the immune system. ...More…
-
SEER Stat Fact Sheets - Non-Hodgkin Lymphoma
National Cancer Institute — It is estimated that 66,120 men and women (35,450 men and 30,670 women) will be diagnosed with and 19,160 men and women will die of non-Hodgkin lymphoma in 20081X Close From 2001-2005, the median age at diagnosis for non-Hodgkin lymphoma was 67 ...More…
-
SEER Stat Fact Sheets - Lymphoma
National Cancer Institute — It is estimated that 74,340 men and women (39,850 men and 34,490 women) will be diagnosed with and 20,510 men and women will die of lymphoma in 20081X Close From 2001-2005, the median age at diagnosis for lymphoma was 64 years of age3X Close The ...More…
-
Study Suggests New Options for Follicular Lymphoma
National Cancer Institute — Adapted from the NCI Cancer Bulletin, vol. 5/no. 21, Oct. 21, 2008 (see the current issue). Treatment with a radiolabeled monoclonal antibody appears to be highly effective as consolidation after first-line therapy in patients with indolent, ...More…
-
General Information About Childhood Non-Hodgkin Lymphoma
National Cancer Institute — Childhood non-Hodgkin lymphoma is a disease in which malignant (cancer) cells form in the lymph system. There are four major types of childhood non-Hodgkin lymphoma. Possible signs of childhood non-Hodgkin lymphoma include breathing problems and ...More…
-
Glossary - Mantle Cell Lymphoma Consortium
The following pages contain a glossary of some of the most common terms that your doctor may use, or that you may find in things you read about lymphoma. It is Glossary of Lymphoma-Related Terms Organizational Chart A Patient's Perspective Events ...More…
-
Follicular Lymphoma Treatment Better With Rituximab
National Cancer Institute — Follicular lymphoma, rituximab (Rituxan®), monoclonal antibody. (Definitions of many terms related to cancer can be found in the Cancer.gov Dictionary.) In patients with newly diagnosed follicular lymphoma, the addition of rituximab, a monoclonal ...More…
-
"Lymphoma, Non-Hodgkin"
Clinical Trials — Tailoring Treatment for B Cell Non-Hodgkin's Lymphoma Based on PET Scan Results Mid Treatment Lymphoma, Non-Hodgkin; Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Procedure: Autologous Transplant; Procedure: Allogeneic ...More…
-
"Lymphoma"
Clinical Trials — Study of Bortezomib and Panobinostat to Treat Relapsed/Refractory Peripheral T-Cell Lymphoma or NK/T-Cell Lymphoma Peripheral T-Cell Lymphoma (Not Otherwise Specified); Angioimmunoblastic T-Cell Lymphoma; Extranodal NK/T-Cell Lymphoma Nasal Type; ...More…
-
Coping With Lymphoma
Being diagnosed with lymphoma and receiving treatment can present many emotional and psychological challenges.You may experience a wide range of emotions including fear, anxiety, shock, and disbelief, when you learned you have lymphoma. Often, ...More…
-
General Information About Primary CNS Lymphoma
National Cancer Institute — Primary central nervous system (CNS) lymphoma is a disease in which malignant (cancer) cells form in the lymph tissue of the brain and/or spinal cord. Having a weakened immune system may increase the risk of developing primary CNS lymphoma. Tests ...More…